ABBV

AbbVie Inc. $257.12 1M +3.4% 3M +14.4% YTD +12.1% as of 2026-09-11
+Watchlist

next ticker · + or scroll to zoom · pan · 0 reset

▲ buy   ▼ sell  ·  size ≈ trade size  · earnings beat miss  ·  ring before open after close  ·  moving averages · click the buttons above to hide them

Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+0.2%
Next 1 week
-0.2%
Next 1 month
-0.9%
Seasonality
No real seasonal tilt
Next 30 days (to Oct 13): -0.2% median, 50% of the last 12 years finished up.
20-year seasonality chart →
Mean reversion
Neutral — RSI(2) at 79
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is -0.04%/day.
Mean-reversion stats →
1-month breakdown — Market · β -0.07 -0.0% · Seasonal tilt -0.9%
$454.1B market cap (#24 US) $1.1B/day volume 27% volatility +22% 1-year -4% from ATH
52-week range · 87% of the way up · -4% from the high
$190.75$267.47

Congressional trades in ABBV Full tracker →

52 members · 86 buys / 79 sells · $1.3M–$5.0M disclosed · latest filing Jul 21, 2026.

BUY AA Alan Armstrong · traded Mar 27, 2026 $15K–$50K
SELL JG Josh Gottheimer · traded May 5, 2026 $1K–$15K
SELL JJ Julie Johnson · traded Dec 18, 2025 $1K–$15K
SELL JL Julia Letlow · traded Dec 8, 2025 $1K–$15K
SELL JL Julia Letlow · traded Jan 24, 2025 $1K–$15K
BUY JL Julia Letlow · traded Oct 23, 2024 $1K–$15K
BUY JL Julia Letlow · traded Apr 28, 2025 $1K–$15K
SELL JJ Julie Johnson · traded Nov 13, 2025 $1K–$15K

Earnings Full history →

Next report 2026-10-29 (Thursday, before open, in 46 days) · EPS est. 3.84.

1-day std dev
4.2%
Finished up
55%
Biggest pop
+13.8%
Biggest drop
-8.0%

Standard deviation of the close-to-close move over the last 55 reports. History, not a forecast.

Data from the U.S. House Clerk and FINRA, plus end-of-day prices. Not investment advice.